An Act concerning the regulation of Kratom
Massachusetts bill proposes regulatory framework for kratom sales, establishing production standards and labeling requirements to address consumer protection and public health concerns.
Massachusetts bill proposes regulatory framework for kratom sales, establishing production standards and labeling requirements to address consumer protection and public health concerns.
SD 806 proposes to establish regulatory oversight for kratom, a plant-derived substance containing alkaloids that produce psychoactive effects. The bill would likely create standards for kratom production, sales, labeling, and distribution in Massachusetts, similar to how other states regulate botanicals and dietary supplements with potential health effects.
Kratom exists in a legal gray area in most U.S. jurisdictions—not controlled as a drug but also largely unregulated. This creates consumer protection gaps regarding product purity, potency, and safety, while also creating uncertainty for retailers. Massachusetts would join a handful of states attempting to establish clear regulatory frameworks that balance public health concerns with market access.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.